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The susceptibilities of 135 coryneform bacteria isolated from clinical samples to ampicillin (AMP), ceph-
alothin (CR), cefoxitin (FOX), cefotaxime (CTX), erythromycin (E), ciprofloxacin (CIP), tetracycline (TE),
amikacin (AK), vancomycin (VA), and rifampin (R) were determined by disk diffusion, broth microdilution,
and the E-test. The following species (number of isolates in parentheses) were included: Corynebacterium
urealyticum (30), Corynebacterium minutissimum (20), coryneform CDC group ANF-1 (20), Corynebacterium
striatum (20), Corynebacterium jeikeium (15), coryneform CDC group I2 (8), Listeria monocytogenes (7), Coryne-
bacterium xerosis (5), and other coryneform bacteria (10). Agreement within one twofold dilution between the
E-test and broth microdilution was 31% (VA), 64% (AK), 71% (CTX), 77% (FOX and CIP), 79% (TE), 84%
(AMP), 87% (E), and 88% (CR and R). For the 1,350 combinations of microorganisms and antimicrobial
agents, 85 (6.3%) discrepancies in interpretive category were found (4.2% minor, 1.2% major, and 0.9% very
major). Seventy (5.1%) disagreements in interpretive category were found between disk diffusion and the E-test
(3.8% minor, 0.4% major, and 0.9% very major), and 85 (6.3%) disagreements were found between microdi-
lution (reference method) and disk diffusion (4.2% minor, 0.5% major, and 1.5% very major). MICs obtained
with the E-test were highly reproducible. No category discrepancy was observed for VA, despite quantitative
results. Considering interpretive categories, there is a good overall agreement between the three methods
studied here, but further evaluation of current methodologies for susceptibility testing is required when
considering coryneform bacteria and determination of quantitative activity of antimicrobial agents.
Coryneform bacteria other than Corynebacterium diphtheriae
have often been considered contaminant organisms, but there
is increasing evidence of the clinical importance of several
organisms including Corynebacterium jeikeium, Corynebacte-
rium urealyticum, Corynebacterium striatum, Arcanobacterium
haemolyticum, Actinomyces pyogenes, Rhodococcus equi, and
other species (3). There are few reports on the activity of
antimicrobial agents against coryneform bacteria. The majority
refer to C. jeikeium or C. urealyticum (4, 12, 13) or to particular
groups of antimicrobial agents (8). Both C. jeikeium and C.
urealyticum are fastidious slowly growing organisms, which lim-
its the use of traditional susceptibility testing assays. In fact, the
methodology used in previous reports is not uniform, and at
this moment the National Committee for Clinical Laboratory
Standards (NCCLS) has not yet provided specific guidelines
for the testing of these organisms. Also, most of the ap-
proaches using commercial panels for routine susceptibility
testing of clinically important bacteria have not yet been eval-
uated for the testing of coryneform bacteria. These factors
hinder the determination in the clinical laboratory of the quan-
titative activity of antimicrobial agents against coryneform bac-
teria.
The E-test provides a simple, rapid, and reliable method for
determining quantitative activity of antimicrobial agents
against microorganisms, including gram-negative bacilli, gram-
positive cocci (1, 2), and fastidious bacteria such as Streptococ-
cus pneumoniae and Haemophilus influenzae (6). Moreover, it
has been reported (9) that this method is cost-effective when a
limited number of antimicrobial agents is studied. The E-test
could be a useful method for susceptibility testing of coryne-
bacteria, including C. jeikeium, C. urealyticum, and other fas-
tidious organisms within this group.
The purpose of this study is to evaluate the activity of 10
antimicrobial agents against coryneform bacteria isolated from
clinical samples by three different methods: disk diffusion, mi-
crodilution, and the E-test.
(This work was presented in part at the 34th Interscience
Conference of Antimicrobial Agents and Chemotherapy in
Orlando, Fla. [7]).
MATERIALS AND METHODS
Bacteria. One hundred and thirty-one coryneform bacteria isolated from clin-
ical samples at the Hospital Universitario ‘‘Virgen Macarena,’’ Seville, Spain, in
the period 1991 to 1992, and four ATCC strains were evaluated. Bacteria were
identified by the method of Hollis and Weaver (5); identification was confirmed
by using the API CORYNE System. The following species were tested (number
of isolates in parentheses): C. urealyticum (30, including strains ATCC 43042,
ATCC 43043, and ATCC 43044), Corynebacterium minutissimum (20), coryne-
form CDC group ANF-1 (20), C. striatum (20), C. jeikeium (15 including strain
ATCC 43734), coryneform CDC group I2 (8), Listeria monocytogenes (7),
Corynebacterium xerosis (5), Corynebacterium aquaticum (1), coryneform CDC
group A3 (3), coryneform CDC group B (2), coryneform CDC group F (2),
coryneform CDC group A5 (1), and coryneform CDC group ANF-3 (1). After
identification, bacteria were maintained in 10% glycerol in tryptic soy broth at
2708C until they were used. Staphylococcus aureus ATCC 29213 and ATCC
25922 and Enterococcus faecalis ATCC 29212 were used as control strains.
Microdilution assay. An in-house microdilution method was used (8). We
followed the guidelines described by the NCCLS (10) with the exception that
cation-supplemented Mueller-Hinton broth containing 0.5% Tween 80
(MHT80) was used. The following antimicrobial agents were used as powders of
known potency: ampicillin (AMP; Smith-Kline Beecham), cephalothin (CR;
Sigma), cefoxitin (FOX; Merck, Sharp, & Dohme), cefotaxime (CTX; Hoechst),
erythromycin (E; Abbott), ciprofloxacin (CIP; Bayer), tetracycline (TE; Sigma),
amikacin (AK; Bristol Myers), vancomycin (VA; Eli Lilly), and rifampin (R; Ciba
Geigy). Twofold dilutions across a range of 0.015 to 16 mg/ml for E, CIP, and R;
0.06 to 64 mg/ml for AMP, TE, and VA; and 0.125 to 128 mg/ml for CR, FOX,
CTX, and AK were used. The inoculum (5 3 104 CFU per well) was prepared
in MHT80 from cultures grown on Columbia agar with 5% sheep blood for 20 to
24 h. Plates were incubated aerobically at 358C for 18 h or in the case of C.
jeikeium and C. urealyticum, for 24 h, since with both species there was no visible
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growth in the control wells at 18 h. The MIC was determined to be the lowest
concentration of antimicrobial agent that inhibited visible growth.
Disk diffusion assay. Plates containing Mueller-Hinton agar supplemented
with 5% sheep blood and 0.5% Tween 80 were used. The inoculum was prepared
by suspending bacteria grown on Columbia agar with 5% sheep blood for 20 to
24 h in MHT80 to a concentration of about 108 CFU/ml. Plates were inoculated
with a cotton swab according to the NCCLS guidelines for this procedure (11).
Afterwards, disks containing the following antimicrobial agents (Difco) were
aseptically placed on the surface of the plates: AMP (10 mg), CR (30 mg), FOX
(30 mg), CTX (30 mg), E (15 mg), CIP (5 mg), TE (30 mg), AK (30 mg), VA (30
mg), and R (5 mg). Plates were incubated aerobically for 18 h or for 24 h in the
case of C. jeikeium and C. urealyticum.
E-test. The conditions for disk diffusion were also followed for the E-test,
except that E-test strips (Biodisk, Solna, Sweden) instead of disks containing the
antimicrobial agents were applied to the surface of the plates. For each micro-
organism, two 150-mm-diameter plates were used, and five strips were applied to
each agar surface. The MICs were read at the point of intersection between the
edge of the zone of bacterial growth and the E-test strip following incubation as
described above.
Control strains were used as follows: S. aureus ATCC 29213 and E. faecalis
ATCC 29212 for microdilution and E test and S. aureus ATCC 25923 for disk
diffusion and E test.
The reproductibility of the E-test was assessed by performing the assay five
times over 5 days with one clinical isolate each of C. jeikeium, C. striatum, L.
monocytogenes, C. minutissimum, and C. urealyticum.
Evaluation criteria. Because of the absence of accepted breakpoints for as-
signment of coryneform bacteria to interpretive categories, those established for
microdilution (10) and disk diffusion (11) by the NCCLS for organisms other
than Haemophilus species and Neisseria gonorrhoeae were used. In the case of
AMP, the breakpoint for L. monocytogenes (the only gram-positive rod specifi-
cally included by the NCCLS) was considered. Because studies on the clinical
effectiveness of vancomycin against coryneform bacteria are lacking, the break-
points for ‘‘other gram-positives’’ (not those for enterococci) were used. For
comparison of MICs determined by microdilution and E-test results, the latter
MICs were rounded up to the next higher twofold dilution value. Disagreements
of the E-test with either microdilution or disk diffusion or of disk diffusion with
microdilution (the reference method) were classified as very major (false sus-
ceptibility), major (false resistance), or minor (disagreement because of an in-
termediate result by either the evaluated method or the reference method and
susceptibility or resistance with the other method).
RESULTS
The distribution of differences in MICs determined by ref-
erence microdilution and the E-test are presented in Table 1.
Agreement within one twofold dilution between the E-test and
the MIC reference method was 31.1% for VA, 64.5% for AK,
71.1% for CTX, 77.0% for FOX and CIP, 79.2% for TE, 84.5%
for AMP, 86.6% for E, and 88.2% for CR and R. For the 1,350
combinations of microorganisms and antimicrobial agents, 85
(6.3%) disagreements in interpretive category were found. As
shown in Table 2, 57 (4.2%) of the disagreements were minor,
16 (1.2%) were major, and 12 (0.9%) were very major discrep-
ancies.
Discrepancies between interpretive categories determined
by the E-test and the disk diffusion method are presented in
Table 3. For the 1,350 combinations of microorganisms and
antimicrobial agents, 70 (5.1%) disagreements in interpretive
category were found: 52 (3.8%) minor, 6 (0.4%) major, and 12
(0.9%) very major. Comparatively, as shown in Table 4, 85
(6.3%) discrepancies were observed when disk diffusion and
microdilution methods (microdilution as the reference test)
were compared: 57 (4.2%) minor, 7 (0.5%) major, and 21
(1.5%) very major. No disagreement in interpretive categories
for VA were observed when values of any of the three methods
evaluated were compared.
MICs obtained with the E-test were highly reproducible. For
the five tests performed on different days with five different
species (250 results), we found 8 (3.2%) out of one twofold
dilution from the most frequent MIC, specifically, in 2 cases
with FOX and VA and in 1 case (each) with CTX, E, CIP, and
TE.
DISCUSSION
There has been increasing interest on the clinical impor-
tance of coryneform bacteria in recent years, but only a few
reports have dealt with their antimicrobial susceptibility testing
and characteristics. Development of standard methodology for
routine antimicrobial agent testing of these organisms in the
clinical microbiology laboratory seems warranted.
TABLE 1. Distribution of differences in MICs of ten antimicrobial agents against 135 coryneform bacteria by
E-test versus microdilution reference method
Antimicrobial
agent
% of isolates with the following difference in MIC:
% Agreementa
,23 23 22 21 0 11 12 13 .13
AMP 0.7 1.5 2.2 11.1 57.8 15.6 5.9 2.2 3.0 84.5
CR 0 0 0.7 1.5 66.7 20.0 5.9 2.2 3.0 88.2
FOX 1.5 1.5 8.1 9.6 57.8 9.6 7.4 0.7 3.7 77.0
CTX 3.0 5.2 5.2 8.9 56.3 5.9 6.7 4.4 4.4 71.1
E 3.0 3.0 1.5 4.4 77.8 4.4 1.5 0 4.4 86.6
CIP 0 0 1.5 5.9 51.1 20.0 13.3 3.7 4.4 77.0
TE 0 2.2 4.4 3.7 60.7 14.8 8.9 4.4 0.7 79.2
AK 0.7 0 0 2.2 46.7 15.6 16.3 8.9 9.6 64.5
VA 0 0 0.7 0.7 8.9 21.5 41.5 17.0 9.6 31.1
R 0 0.7 0.7 1.5 77.8 8.9 5.9 1.5 3.7 88.2
All agents 0.9 1.4 2.5 5.0 56.2 13.5 11.3 4.6 4.6 74.7
a Percentage of isolates within the accuracy limits of the reference tests (MIC 6 1 log2 dilution).
TABLE 2. Discrepancies between MICs determined by the E-test
and the microdilution reference method (n 5 135)
Antimicrobial
agent
% of isolates by error category
Very major Major Minor Total
AMP 1.5 1.5 0 3.0
CR 0 1.5 1.5 3.0
FOX 0 1.5 6.7 8.2
CTX 0 1.5 9.6 11.1
E 2.2 3.7 5.2 11.1
CIP 0.7 0 8.9 9.6
TE 3.0 0 3.7 6.7
AK 0.7 0.7 2.2 3.6
VA 0 0 0 0
R 0.7 1.5 4.4 6.6
Total 0.9 1.2 4.2 6.3
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We have previously studied the activity of several quinolones
against coryneform bacteria (8) and noted that both C.
jeikeium and C. urealyticum grew satisfactorily on MHT80 with
a 24-h incubation period. In this study, we used MHT80 to
ensure the growth of all organisms. Five percent sheep blood
was added to agar plates to improve the ease of reading zones
of inhibition around disks or strips, especially when testing
slowly growing organisms.
Traditionally, disk diffusion and microdilution have been
used for bacterial susceptibility testing. In routine MIC deter-
mination, the E-test could serve as an alternative to microdi-
lution. To our knowledge, there are no data on the use of
automated methods for susceptibility testing of coryneform
bacteria, another possibility.
When interpretive categories are considered, the data of this
study show good agreement between the three methods used.
Discrepancies were noted in 6.3% (E-test versus microdilu-
tion), 5.1% (E-test versus disk diffusion), and 6.3% (disk dif-
fusion versus microdilution) of comparisons. Most of these
discrepancies were within the minor category (4.2, 3.8, and
4.2%, respectively). On the other hand, when the two quanti-
tative methods are compared, the overall agreement is lower.
As shown in Table 1, the agreement within one twofold dilu-
tion of the E-test with microdilution was only 31.1% for VA
and 64.5% for AK. Agreement for all other antimicrobial
agent values ranged from 71.1% (CTX) to 88.2% (CR and R).
The MICs of VA (determined by microdilution) against 127 of
the 131 strains we tested ranged from 0.06 to 0.5 mg/ml. This
narrow range of variation has been shown to reduce the cor-
relation coefficient between microdilution and the E-test for
other gram-positive bacteria (1).
The actual causes of the discrepancies observed between the
E-test and either broth microdilution or disk diffusion are not
known. The actual causes of the differences observed between
the E-test and broth microdilution could be dependent on the
different nature of assays, but this explanation seems unlikely
for the discrepancies between the E-test and disk diffusion,
since the same laboratory conditions were used for both meth-
ods. The data of Table 4 suggest that the number of discrep-
ancies between disk diffusion and broth microdilution is similar
to that of the E-test with either method.
The E-test is a simple and easy to interpret method, which
does not require special equipment. Its versatility allows the
choice of particular antimicrobial agents. This feature, less
likely available with use of commercial panels containing pre-
determined agents, may be advantageous when a limited num-
ber of antibiotics are to be tested (9). Data in this study show
that although quantitative results obtained with the E-test (es-
pecially for VA and to a lesser extent AK) are not in complete
agreement with microdilution results, the translation of MICs
to interpretive categories highly correlates with those of either
microdilution or disk diffusion. In our opinion, the E-test is as
reliable as broth microdilution or disk diffusion to study the
susceptibility testing of coryneform bacteria.
Very major errors were more frequently encountered when
comparing disk diffusion with microdilution than when com-
paring the E-test with either method (Tables 2, 3, and 4), which
suggests methodological problems in susceptibility testing of
coryneform bacteria. Further studies considering the most ap-
propriate medium, incubation conditions, and breakpoint def-
inition for interpretive categories are necessary in order to
advance our knowledge of the activity of antimicrobial agents
against coryneform bacteria.
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the E-test with broth microdilution for susceptibility testing of coryneform
bacteria, abstr. D16, p. 121. In Abstracts of the 34th Interscience Conference
on Antimicrobial Agents and Chemotherapy. American Society for Micro-
biology, Washington, D.C.
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